BUNTING K.D., BRADLEY H.L., HAWLEY T.S., MORIGGL R., SORRENTINO B.P., IHLE J.N. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. Blood, 2002, 99, 479-487.
ILARIA R.L. JR, HAWLEY R.G., VAN ETTEN R.A. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood, 1999, 93, 4154-4166.
LEE C.K., RAZ R., GIMENO R., GERTNER R., WISTINGHAUSEN B., TAKESHITA K., DEPINHO R.A., LEVY D.E. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSFdependent differentiation. Immunity, 2002, 17, 63-72.
SNOW J.W., ABRAHAM N., MA M.C., ABBEY N.W., HERNDIER B., GOLDSMITH M.A. STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. Blood, 2002, 99, 95-101.
FIÉVEZ L ., KIRSCHVINK N., DOGNÉ S., JASPAR F., MERVILLE M.-P., BOURS V., LEKEUX P., BUREAU F. Impaired accumulation of granulocytes in the lung during ozone adaptation. Free Radic. Biol. Med., 2001, 31, 633-641.
TURLEJ R., FIÉVEZ L. (co-premier auteur), SANDERSEN C., DOGNÉ S., KIRSCHVINK N., LEKEUX P., BUREAU F. Enhanced survival of lung granulocytes in an animal model of asthma : evidence of a role for GM-CSF-activated STAT5 signalling pathway. Thorax, 2001, 56, 696-702.
FIÉVEZ L., DESMET C., HENRY E., HEGENBARTH S., GARZÉ V., PAJAK B., BEX F., MÉLOTTE D., BOUTET P., GILLET L., VANDERPLASSCHEN A., KNOLLE P.A., MOSER M., LEO O., LEKEUX P., BUREAU F. STAT5 is an ambivalent regulator of neutrophil homeostasis. Soumis dans Immunity.
FIÉVEZ L., DESMET C., MÉLOTTE D., LEKEUX P., BUREAU F. STAT5 is essential for neutrophil apoptosis delay during inflammation. en préparation.
FIÉVEZ L., SEUMOIS G., LEKEUX P., BUREAU F. L'apoptose du neutrophile. Ann. Méd. Vét., 2005, 149, 10-19.